Madrigal Pharmaceuticals, Inc.
DE ˙ DB ˙ US5588681057
426,20 € ↑6,40 (1,52%)
2026-06-04
DEL PRIS
SecurityDE:YDO1 / Madrigal Pharmaceuticals, Inc.
InstitutionVerity Asset Management, Inc.
Latest Disclosed Ownership1,164 shares
Latest Disclosed Value $ 609,319
Verity Asset Management, Inc. reports 0.52% increase in ownership of YDO1 / Madrigal Pharmaceuticals, Inc.

On April 21, 2026 - Verity Asset Management, Inc. filed a 13F-HR form disclosing ownership of 1,164 shares of Madrigal Pharmaceuticals, Inc. (DE:YDO1) valued at $524,149 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 30, 2026 disclosing 1,158 shares of Madrigal Pharmaceuticals, Inc.. This represents a change in shares of 0.52% during the quarter. The current value of the position is $496,097 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-21 2026-03-31 13F MADRIGAL PHARMACEUTICALS C 558868105 1,164 6 0.52 609 -9.64 0.2556
2026-01-30 2025-12-31 13F MADRIGAL PHARMACEUTICALS C 558868105 1,158 -102 -8.10 674 16.81 0.2895
2025-11-14 2025-09-30 13F MADRIGAL PHARMACEUTICALS C 558868105 1,260 -457 -26.62 578 11.18 0.1887
2025-08-05 2025-06-30 13F MADRIGAL PHARMACEUTICALS C 558868105 1,717 157 10.06 520 0.58 0.2482
2025-04-25 2025-03-31 13F MADRIGAL PHARMACEUTICALS C 558868105 1,560 70 4.70 517 12.42 0.2102
2025-01-27 2024-12-31 13F MADRIGAL PHARMACEUTICALS C 558868105 1,490 24 1.64 460 47.59 0.2590
2024-10-31 2024-09-30 13F MADRIGAL PHARMACEUTICALS C 558868105 1,466 101 7.40 311 -18.59 0.1171
2024-08-08 2024-06-30 13F MADRIGAL PHARMACEUTICALS C 558868105 1,365 -209 -13.28 382 -9.05 0.1500
2024-05-28 2024-03-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 1,574 -1,115 -41.47 420 -32.48 0.2345
2024-02-08 2023-12-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 2,689 2 0.07 622 58.67 0.3969
2023-11-22 2023-09-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 2,687 721 36.67 392 -13.66 0.2891
2023-08-16 2023-06-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 1,966 492 33.38 454 27.17 0.3368
2023-05-24 2023-03-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 1,474 452 44.23 357 20.61 0.2131
2023-02-14 2022-12-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 1,022 -2,830 -73.47 297 -99.88 0.2537
2022-11-16 2022-09-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 3,852 1,051 37.52 250,341 90,933.09 0.2583
2022-05-23 2022-03-31 13F/A-1 MADRIGAL PHARMACEUTICALS COM 558868105 2,801 145 5.46 275 22.22 0.1748
2022-05-12 2022-03-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 6,726 4,070 275 0.1990
2022-02-08 2021-12-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 2,656 -320 -10.75 225 -5.06 0.1329
2021-11-10 2021-09-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 2,976 618 26.21 237 3.04 0.1535
2021-08-04 2021-06-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 2,358 49 2.12 230 -14.81 0.1260
2021-05-10 2021-03-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 2,309 464 25.15 270 31.71 0.1611
2021-02-05 2020-12-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 1,845 1,845 205 0.1429
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.